Stéphane Mornet received his Ph.D. in physical chemistry of condensed matter at the University of Bordeaux in 2002. After a 4 years post-doctoral fellowship at the European Institute of Chemistry and Biology of Bordeaux, he undertook a post-doctoral position from 2006 to 2007 in Italy at the Institute for Health and Consumer Protection (Ispra) where he worked for the European Commission in the field of NP health risk. He is currently researcher at the French National Centre for Scientific Research (CNRS) at the Institute of Condensed Matter Chemistry of Bordeaux. His research, at the interface of chemistry and biology, focuses on the synthesis of hybrid mono/multifunctional NPs. His objectives are to define nanoscale surface modification strategies in the aim to address critical issues in fields related to nanomedicine and bioimaging. In particular, he is currently developing optimized surface chemistry routes for intravenously administered long circulating NPs; for bioconjugation (antibodies and fragments, proteins, peptides, aptamers, nucleic acids, lipids) in biomolecular imaging (MRI, NIR fluorescence imaging); for the design of thermosensitive nanocarriers (silica-based mesoporous NPs) for heat-triggered drug release induced under a magnetic field (magnetic) or near infra-red irradiation (plasmonic); and for the design of biofunctionalized magnetic nanoparticles for extracellular vesicles extraction from biological fluids.